Show simple item record

dc.contributor.authorvan Dongen, Johanna M
dc.contributor.authorPersoon, Saskia
dc.contributor.authorJongeneel, Gabrielle
dc.contributor.authorBosmans, Judith E
dc.contributor.authorKersten, Marie José
dc.contributor.authorBrug, Johannes
dc.contributor.authorNollet, Frans
dc.contributor.authorChinapaw, Mai J M
dc.contributor.authorBuffart, Laurien M
dc.date.accessioned2019-10-21T16:13:33Z
dc.date.available2019-10-21T16:13:33Z
dc.date.issued2019-08-01
dc.identifier.issn1932-2267
dc.identifier.pmid31286387
dc.identifier.doi10.1007/s11764-019-00775-9
dc.identifier.urihttp://hdl.handle.net/10029/623351
dc.description.abstractOne hundred nine patients were randomly assigned to the exercise intervention (n = 54) or the usual care control group (n = 55). Data on cardiorespiratory fitness (VO2peak), handgrip strength, general fatigue, and health-related quality of life (quality-adjusted life years [QALYs]) were collected at baseline (T0), after completion of the exercise intervention or at a similar time point in the control group (T1) and 12 months later (T2). Cost questionnaires were used to assess societal costs. Long-term effectiveness (at T2) was evaluated using linear mixed model analyses. For the economic evaluation, missing data were imputed using multiple imputation, and data were analyzed using linear mixed models.en_US
dc.language.isoenen_US
dc.subjectCost-effectivenessen_US
dc.subjectExercise interventionen_US
dc.subjectLong-term effectivenessen_US
dc.subjectLymphomaen_US
dc.subjectMultiple myelomaen_US
dc.titleLong-term effectiveness and cost-effectiveness of an 18-week supervised exercise program in patients treated with autologous stem cell transplantation: results from the EXIST study.en_US
dc.typeArticleen_US
dc.identifier.journalJ Cancer Surviv 2019; advance online publication (ahead of print)en_US
dc.source.journaltitleJournal of cancer survivorship : research and practice


This item appears in the following Collection(s)

Show simple item record